Last reviewed · How we verify
NCT04458025: RAPIDREHAB
Prospective, Randomized Clinical Trial Comparing Early Versus Delayed Postoperative Mobilization After Arthroscopic Rotator Cuff Tear Reapair.
NA trial testing Standard rehabilitation program in Rotator Cuff Tear Repair in 64 participants. Status unknown.
30 September 2023
Quick facts
| Lead sponsor | Borja Alcobía-Díaz MD, PhD |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 64 |
| Start date | 1 September 2020 |
| Primary completion | 30 September 2023 |
| Estimated completion | 31 December 2023 |
Drugs / interventions tested
- Standard rehabilitation program
- Early rehabilitation program
Conditions studied
- Rotator Cuff Tear Repair — all drugs for Rotator Cuff Tear Repair →
Sponsor
Borja Alcobía-Díaz MD, PhD
Who can join
Adults 18 to 70, any sex, with Rotator Cuff Tear Repair. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Arthroscopic suture for complete and partial \>50% thickness Rotator Cuff Tears (RCT) is the gold standard. However, there is no evidence of superiority of delayed postoperative mobilization protocols versus early ones, in terms of ROM, pain, quality of life and complications in last review published in 2019 by AAOS. Although, excessive immobilization can lead into stiffness, neuropathic pain or adhesive capsulitis. All of these are complications which can diminish patient quality of life or prolong their return to work or sports activities. This is an experimental, prospective, non-blind, comparative, randomized clinical trial, between two options of treatment. On one treatment branch, we will continue applying our standard postoperative 4 weeks immobilization rehabilitation program with a sling in adduction and internal rotation. On the other treatment branch, we will start passive mobilization during second week after surgery, including controlled external rotation movements. All recruited patients will be followed-up during 12 months. Our main objective is to compare differences in terms of functionality (using ASES scale). Secondary objectives are to compare differences in terms of ROM, functionality (using CMS and UCLA scales), pain (using VAS score), need of analgesic drugs, quality of life (using EQ-5D scale), return to previous work and sports activities, patient adhesion to protocol, complications and MRI rotator cuff retear ratio at 12 months follow-up. After this study, we hope to develop a new postoperative mobilization protocol for patients. This protocol will be focused on timing, and self-administrated exercises in order to involve patients in their recovery, in the fastest and safest way for them.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04458025
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Standard rehabilitation program
Trials testing the same drug.
- NCT07525752 — Carry-Over Effects of Lower Limb Cross-Training Priming on Upper Limb Function in Children With Unilateral Cerebral Pals · NA · completed
- NCT07431671 — Feeding Disorders in Children · NA · recruiting
- NCT05434767 — Evaluating the Feasibility and Effectiveness of Using a Smartphone Application During Rehabilitation in Patients After T · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04458025 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Borja Alcobía-Díaz MD, PhD
- Last refreshed: 7 July 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04458025.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing